Active Ingredient(s): Midodrine
FDA Approved: * September 6, 1996
Pharm Company: * SHIRE
Category: Blood Pressure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

ProAmatine Overview

Midodrine is a vasopressor/antihypotensive agent. Midodrine was approved in the United States by the Food and Drug Administration (FDA) in 1996 for the treatment of dysautonomia and orthostatic hypotension. In August 2010, the FDA proposed withdrawing this approval because the manufacturer, Shire plc, failed to complete required studies after the medicine reached the market.[1][2] In September 2010, the FDA reversed its decision to remove midodrine from the m...

Read more ProAmatine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent ProAmatine Forums: RSS Feed

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Tablet: 10mg, 2.5mg, 5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for ProAmatine: (4 results)

Sorted by National Drug Code
  • 54092-003 Proamatine 2.5 mg Oral Tablet by Shire Us Manufacturing Inc.
  • 54092-004 Proamatine 5 mg Oral Tablet by Shire Us Manufacturing Inc.
  • 54092-007 Proamatine 10 mg Oral Tablet by Shire Us Manufacturing Inc.
  • 54868-5442 Proamatine 5 mg Oral Tablet by Physicians Total Care, Inc.

Other drugs which contain Midodrine or a similar ingredient: (2 results)